INmune Bio reports EEG improvement in Alzheimer’s therapy By Investing.com
© Reuters.
BOCA RATON, FL - INmune Bio, Inc. (NASDAQ:INMB), a clinical-stage immunology company, announced significant improvements in brain function in patients with moderate to severe Alzheimer's Disease (AD) after four weeks of…
